Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Apraglutide by Ironwood Pharmaceuticals for Short Bowel Syndrome: Likelihood of Approval
Apraglutide is under clinical development by Ironwood Pharmaceuticals and currently in Phase III for Short Bowel Syndrome. According to GlobalData,...
Data Insights
Apraglutide by Ironwood Pharmaceuticals for Short Bowel Syndrome: Likelihood of Approval
Apraglutide is under clinical development by Ironwood Pharmaceuticals and currently in Phase III for Short Bowel Syndrome. According to GlobalData,...